V Ventures

Vventures support cutting-edged technology investment focus on sustainability, urbanization and life-science on AI and quantum based. In the heart of SEA, Vventures operates in Singapore and Thailand while invested worldwide in USA, UAE, Israel, Singapore, Hong Kong and China.

Miranda Son

General Partner

9 past transactions

Deemples

Venture Round in 2024
Deemples is a prominent golf application based in Malaysia, catering to a community of 60,000 golfers who utilize the platform to find and join local golf games. The app allows users to create and manage personal profiles, track handicaps, and connect with other golf enthusiasts, thus enhancing their golfing experience. Over 70 golf courses partner with Deemples to facilitate payments, streamlining the booking process for users. Currently, the company is in the process of raising funds to support its expansion into Thailand, Indonesia, and eventually the United States, aiming to broaden its reach and serve a larger audience of golf players.

SCREENSHOT Media

Seed Round in 2023
SCREENSHOT Media is a contemporary media company that operates both online and in print, catering to a new generation of readers. It focuses on delivering unique narratives about current affairs through a lens that encompasses four key topics: technology, visual cultures, politics, and the future. The company aims to engage its audience by offering honest stories that spark curiosity and provoke thought on moral and ethical issues relevant to everyday life. By providing a diverse range of content, SCREENSHOT Media positions itself as a platform for insightful news and entertainment, appealing to those interested in the intersection of these dynamic fields.

Zipmex

Acquisition in 2022
Zipmex is a digital asset exchange platform that facilitates secure investments in cryptocurrencies for both retail and institutional investors. Founded in August 2018 by Akalarp Yimwilai and Marcus Lim in Singapore, the company aims to provide curated investment opportunities that include asset-backed digital assets like gold and real estate, as well as established cryptocurrencies with significant wealth generation potential. Zipmex prioritizes security by employing institutional custody for digital assets, offering insurance coverage up to $100 million. The platform features advanced trading tools and charting capabilities, catering to a diverse user base. Currently, Zipmex is licensed to operate in Thailand and Australia, and it is actively pursuing licenses in Indonesia and Singapore.

Fraction

Seed Round in 2022
Fraction is a technology company that provides a fractional ownership infrastructure on an internet-scale. Users can invest in, sell, and manage fractional ownership of anything using its plug-and-play platform. Its products enable fractional ownership for real estate developers, small and medium-sized businesses, investment funds and pooled capital, and everything in between.

Advanto

Seed Round in 2021
Advanto is a financial services firm focused on enhancing the financial wellness of frontline workers. The company has developed a fintech platform that enables employees to access a portion of their earned wages in real-time, allowing them to withdraw their salary at any point during the month, independent of traditional payday schedules. This service aims to help employees avoid predatory installment products and the cycle of debt that can arise from delayed wage access. By facilitating timely access to earned wages, Advanto supports individuals in managing their financial needs more effectively.

Blender

Corporate Round in 2018
Blender is a global Fintech company based in Ramat Gan, Israel, that operates a peer-to-peer lending platform connecting loan recipients with providers. Founded in 2014, Blender utilizes its proprietary DirectMatch system, which employs mathematical algorithms to optimize the matching of borrowers' requests with lenders' terms. The company also offers a secondary trading market called Re-BLend, allowing lenders to buy and sell loans and portfolios among themselves, enhancing investment opportunities. Blender primarily focuses on Buy Now Pay Later (BNPL) services and auto loans, striving to deliver innovative credit and financing solutions to its growing customer base. Currently active in Israel, the Baltics, and Italy, the company is expanding into Poland and Central Europe, with a registered user community of approximately 430,000. Blender has disbursed over NIS 730 million in loans and aims to further develop its digital banking services, having recently completed an IPO and seeking to obtain a European Specialized Banking License.

CYE

Corporate Round in 2017
CYE is a cybersecurity optimization company that offers a platform designed to help businesses assess, quantify, and mitigate cyber risks. The platform performs continuous external assessments of a company's cybersecurity posture and manages the potential risks associated with supply-chain attacks. CYE combines advanced technology with expert guidance from cybersecurity professionals to assist organizations in making informed security decisions and implementing effective remediation strategies. The company caters to a diverse clientele, including Fortune 500 and mid-market companies across various industries worldwide. With headquarters in Israel and additional offices in New York and London, CYE is backed by notable investors.

Owlstone Medical

Corporate Round in 2016
Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.